Throat Cancers Tied to HPV Are Rising Among U.S. Men, Women
TUESDAY, Dec. 21, 2021 -- You might have heard a lot about the human papillomavirus (HPV) and its role in cervical cancer, but this sexually transmitted virus can also cause another type of cancer.
Rates of oropharyngeal cancer, which occurs in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 21, 2021 Category: General Medicine Source Type: news
Tanzania: Health Teams Tasked in Hpv Awareness Creation
[Daily News] COMMUNITY Health Management Teams (CHMT) in district councils have been advised to step up efforts in raising awareness among members of the public on the benefits of Human Papillomavirus Vaccines (HPV1&HPV2) in protecting girls under 15 against cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 14, 2021 Category: African Health Source Type: news
Why More Kids Aren ’t Getting the HPV Vaccine
The human papillomavirus vaccine can prevent six potentially lethal malignancies, but inoculation is meeting with rising resistance from parents. (Source: NYT Health)
Source: NYT Health - December 13, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Human Papillomavirus (HPV) Gardasil (Vaccine) Cervical Cancer Vaccination and Immunization Head and Neck Cancer Sexually Transmitted Diseases Parenting Teenagers and Adolescence Youth Cervarix (Vaccine) JAMA Pediatrics (Journal) Source Type: news
Cancer breakthrough: New blood test may detect cancer earlier and more accurately
THE HUMAN papillomavirus is a group of STDs that can produce cancer in several areas of the body. The most common type of cancer is in the head and neck, and a new blood test may make catching it easier. Symptoms of head and neck cancer can include a sore threat, change in voice and pain in the ears. (Source: Daily Express - Health)
Source: Daily Express - Health - December 8, 2021 Category: Consumer Health News Source Type: news
Tanzania: Send Your Daughters for Hpv Vaccination, Parents Urged
[Daily News] THE MINISTRY of Health, Community Development, Gender, Elderly and Children has urged parents to ensure that their daughters take the Human Papillomavirus Vaccine (HPV) to protect them from cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 1, 2021 Category: African Health Source Type: news
HPV Vaccine Has Protected Thousands Of People From Cervical Cancer, According To New Study
The HPV (human papillomavirus) vaccine pledged to help protect students between the ages of 12 and 13 from cervical cancer, among other cancers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 1, 2021 Category: Pharmaceuticals Authors: Alice Broster, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Single-Dose HPV Vaccination Highly Effective Single-Dose HPV Vaccination Highly Effective
Only 15% of girls globally are vaccinated against human papillomavirus (HPV), but single-dose vaccination could pave the way for much better infection control, new research suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Newspath June 2014 - Role of p16 and Ki67 Immunohistochemistry in the Evaluation of Cervical Dysplasia
Cervical dysplasia refers to abnormal microscopic changes in the cells on the surface of the cervix. It is usually associated with human papillomavirus infection and is frequently detected on Pap smears as "squamous intraepithelial lesions." (Source: NewsPath - Pathology News for the Medical Community)
Source: NewsPath - Pathology News for the Medical Community - November 11, 2021 Category: Pathology Source Type: news
HPV Vaccination:'Dramatic' Reduction in Cervical Cancer HPV Vaccination:'Dramatic' Reduction in Cervical Cancer
New data from England show the success of the national human papillomavirus (HPV) vaccination program in preventing cervical cancer and noninvasive precursor lesions in young women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Older HPV vaccine cuts cervical cancer rate up to 87%, study finds
Young women who were vaccinated against human papillomavirus in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked... #glaxosmithkline #thelancet (Source: Reuters: Health)
Source: Reuters: Health - November 3, 2021 Category: Consumer Health News Source Type: news
HPV vaccination lowers cervical cancer risk up to 87%, British study finds
Becoming vaccinated against the human papillomavirus reduces a woman's risk for cervical cancer up to 87%, a study published Wednesday by the Lancet found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 3, 2021 Category: Consumer Health News Source Type: news
Biotech raises $31M to take HPV drug into clinical trials
Gail Maderis helped launch a biotech company to disrupt deadly cervical cancer. Now, after a first-generation drug failed to hit its efficacy target, Maderis and her Antiva Biosciences Inc. are renewing that pledge with a new compound, a global focus and $31 million in fresh funding.
The money will push Antiva's drug, called ABI-2280, into an early-stage clinical trial targeting high-grade cervical intraepithelial neoplasias — precancerous lesions on the cervix caused by human papilloma virus,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 3, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Inovio, AstraZeneca terminate cancer vaccine partnership
MedImmune Ltd., the global biologics research and development arm of AstraZeneca (NYSE: AZN), is terminating a cancer therapy partnership it has with Inovio Pharmaceuticals.
The partnership, formed in 2015, gave MedImmune of Gaithersburg, Maryland, exclusive rights to Inovio's experimental DNA-based cancer vaccine, known as INO-3112, for cancers caused by human papillomavirus (HPV) types 16 and 18.
MedImmune renamed the new drug candidate as MED10457 after acquirin g its exclusive rights. The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 2, 2021 Category: Pharmaceuticals Authors: John George Source Type: news
Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools.
As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Health - November 1, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools.
As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Science - November 1, 2021 Category: Science Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
